Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Affiris, AGC Biologics, Alivamab, Altus, Amryt, Avectus, Bayer, CB Therapeutics, Celmatix, Distributed Bio, Eleva, Enara Bio, Ervaxx, Evotec, Katana, Kymab, Kymera, Lupin, Mediar, Mitsubishi Tanabe, Novavax, Novellusdx, Octapharma, Pharmabcine, Plexxikon, Pluristem, Regeneron, Swift, Swixx Biopharma, Tenax, Tetra.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Allakos, Amgen, Aprea, Astrazeneca, Beyondspring, BMS, Complexa, Horizon, Innovent, Janssen, Lilly, Novartis, Replimune, Spring Bank, Valerion.

Biopharmas raising money in public or private financings, including: Allena, Apeiron, Arca, Evofem, Innocan, Intellia, Iovance, Iterum, Hyloris, Isofol, Kaleido, Marinus, Mersana, Ourcrowd, Outlook, Pliant, Re-Vana, Shorla, Tae.

New hires and promotions in the biopharma industry, including: Aligos, Confo, Hemostemix, Ocugen, Oxford Biodynamics, Sirtex, Vaxcyte.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Abbvie, Aerpio, Alligator, Anixa, Astrazeneca, Beigene, Biogen, Biotheus, Bold, Carna, Ceapro, Chimeron, Codiak, Daiichi Sankyo, Edigene, Eli Lilly, Emergent, Fujifilm, Heat Biologics, Hitgen, Hua Medicine, Humanigen, Immunitybio, Immunochina, Immutep, Innovation, Jacobio, Kalytera, Mateon, Merck, Moderna, Nantkwest, Novavax, Oncodesign, Ontochem, Organicell, Orpro, Oryzon Genomics, Oxford Biomedica, Praha Vaccines, Proteona, Proteostasis, Puretech, Rakuten Medical, Restorbio, Resverlogix, Seranovo, Shanghai Junshi, Shionogi, Synairgen, Takeda, Tetra, Tolero, Tonix, Toshiba, Twist, Vault, Vir, Virna.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Abivax, Accord Healthcare, Akeso, Algernon, Altimmune, Anivive Lifesciences, Astellas, Beyond Air, Cerecor, Diffusion, Hutchison China Meditech, Immunitybio, Longeveron, Moleculin, Opko Health, Orpheris, Phasebio, Qurient, Radius Health, Shanghai Henlius, Shionogi, Sino, Takeda, Teijin.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Apellis, Atriva, Belx Bio-Pharmaceutical (Taiwan), Calcimedica, CTI Biopharma, Genentech, Gilead Sciences, Glenmark, I-Mab, Mesoblast, Moderna, Novavax, NS Pharma, Partner, Radius Health, Synairgen, Taiwan Liposome, Teijin, Transcenta, Zai Lab.

Biopharmas in Asia-Pacific raising money in public or private financings, including: Genetic Technologies, Outlook, Pneumagen.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Feedback, Gelesis, Philips, Zoll.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Avita Medical, Citius, College Park Industries, Fibralign, Icometrix, Lumendi, Medx, Mölab, Mybio, Myndtec, Maness Veteran Medical, Nuprobe, Ourcrowd, Pathgroup, Protech Home Medical, Qualigen Therapeutics, Respira Technologies, Steeper Group, Surgery Exchange, Technopath Clinical Diagnostics, Terumo.